Patients with multi-system (MS)-type langerhans cell histiocytosis (LCH) show poor outcomes, especially congenital MS LCH cases were shown in high mortality rate. We experienced a congenital case of MS LCH with high risk organs, who needed intensive respiratory support after birth. Even though intensive chemotherapy was discontinued, this patient's lung LCH lesions gradually became reduced and his respiratory condition recovered; therefore, we restarted and completed maintenance chemotherapy. The patient maintained complete remission for more than 4 years after the end of chemotherapy. Our case suggests that congenital MS LCH even with severe organ involvement can be treated successfully with chemotherapy.
|Number of pages||5|
|Journal||Acta medica Okayama|
|Publication status||Published - Jan 1 2019|
- Langerhans-cell histiocytosis
- Multisystem type
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)